Literature DB >> 2170294

Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea.

M E Fini1, M T Girard.   

Abstract

Members of the gelatinase subclass of the matrix metalloproteinase family have the capacity to degrade denatured collagens of all types and native types IV, V, and VII collagens. The authors identified the metalloproteinase species of the gelatinase class produced by the cells of rabbit corneal tissue. Two different molecular forms of gelatinase, visualized as enzymatic activities, that undergo electrophoresis with different mobilities on gelatin zymograms are synthesized by corneal cells in serum-free organ culture. The enzyme species that has the slower mobility is biochemically and immunologically related to a gelatinase synthesized by macrophages and neutrophils which has been called both type IV and type V collagenase. The second gelatinase species is related to a second enzyme, the product of a different gene, which has also been called type IV collagenase. The electrophoretic mobilities of these enzymes on polyacrylamide gels indicate the inactive proenzyme forms. The authors refer to these enzymes as 92-kilodalton (kD) gelatinase and 72-kD gelatinase based on their electrophoretic mobilities under sulfhydryl-reducing conditions. In primary cell culture, corneal epithelial cells were found to synthesize predominantly the 92-kD gelatinase species whereas the 72-kD gelatinase is synthesized mostly by stromal fibroblasts. However, each cell type can produce small amounts of the other enzyme. The 72-kD gelatinase, mostly in the proenzyme form, can be extracted from the normal corneal stroma without culturing, but expression of 92-kD gelatinase can only be detected in cell or organ culture. The substrate specificities of these enzymes suggests that they may be of central importance in the degradation of the epithelial basement membrane and in formation of the epithelial defect that precedes corneal ulceration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170294

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Fibrillin and the eye.

Authors:  J L Ashworth; C M Kielty; D McLeod
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 2.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Expression and distribution of matrix metalloproteinases and their inhibitors in the human iris and ciliary body.

Authors:  J Lan; R K Kumar; N Di Girolamo; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

4.  Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury.

Authors:  M E Fini; W C Parks; W B Rinehart; M T Girard; M Matsubara; J R Cook; J A West-Mays; P M Sadow; R E Burgeson; J J Jeffrey; M B Raizman; R R Krueger; J D Zieske
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 5.  Wounding the cornea to learn how it heals.

Authors:  Mary Ann Stepp; James D Zieske; Vickery Trinkaus-Randall; Briana M Kyne; Sonali Pal-Ghosh; Gauri Tadvalkar; Ahdeah Pajoohesh-Ganji
Journal:  Exp Eye Res       Date:  2014-03-04       Impact factor: 3.467

6.  Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.

Authors:  Gabriel M Gordon; Dolena R Ledee; William J Feuer; M Elizabeth Fini
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

7.  Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Authors:  Francisco Amparo; Mohammad H Dastjerdi; Andre Okanobo; Giulio Ferrari; Leila Smaga; Pedram Hamrah; Ula Jurkunas; Debra A Schaumberg; Reza Dana
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

8.  Evidence for asialo GM1 as a corneal glycolipid receptor for Pseudomonas aeruginosa adhesion.

Authors:  L D Hazlett; S Masinick; R Barrett; K Rosol
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

Authors:  G Perides; R A Asher; M W Lark; W S Lane; R A Robinson; A Bignami
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Matrix metalloproteinases in recurrent corneal melting associated with primary Sjörgen's syndrome.

Authors:  Kristyna Brejchova; Petra Liskova; Enkela Hrdlickova; Martin Filipec; Katerina Jirsova
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.